Tom Dormans

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial

Evelien de Jong, Jos A van Oers, Albertus Beishuizen et al. · The Lancet Infectious Diseases · 2016 · 789 citations · Full text

Antibiotic Treatment, Open-label Trial, Critical Care Medicine +10

Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia

Mirelle Koeman, André van der Ven, Eelko Hak et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 417 citations

Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion

Tom Dormans, J. J. M. Van Meyel, P. G. G. Gerlag et al. · Journal of the American College of Cardiology · 1996 · 320 citations

Heart Failure, Severe Heart Failure, High Dose Furosemide +10

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Sofía Ramiro, Rémy L.M. Mostard, César Magro‐Checa et al. · Annals of the Rheumatic Diseases · 2020 · 231 citations · Full text

Direct Vascular Effects of Furosemide in Humans

Peter Pickkers, Tom Dormans, Frans G. M. Rüssel et al. · Circulation · 1997 · 120 citations